These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
91 related items for PubMed ID: 8818650
21. [Preparation of green fluorescent protein retrovirus and its application in mediating gene transfer into retinal pigment epithelial cells]. Huang Q, Xu P, Liu W, Wang F, Gu Q, Tian S, Fan Y, Xig K, Chen X, Li C. Zhonghua Yan Ke Za Zhi; 2001 Jul; 37(4):248-51. PubMed ID: 11864429 [Abstract] [Full Text] [Related]
22. Generation of a flexible cell line with regulatable, high-level expression of HIV Gag/Pol particles capable of packaging HIV-derived vectors. Sparacio S, Pfeiffer T, Schaal H, Bosch V. Mol Ther; 2001 Apr; 3(4):602-12. PubMed ID: 11319923 [Abstract] [Full Text] [Related]
23. Retrovirus vector containing wild type p53 gene and its effect on human glioma cells. Hlavatý J, Tyukosova S, Bies J, Hlubinova K, Altaner C. Neoplasma; 2000 Apr; 47(4):204-11. PubMed ID: 11043823 [Abstract] [Full Text] [Related]
24. A defective retroviral vector encoding human interferon-alpha2 can transduce human leukemic cell lines. Austruy E, Bagnis C, Carbuccia N, Maroc C, Birg F, Dubreuil P, Mannoni P, Chabannon C. Cancer Gene Ther; 1998 Apr; 5(4):247-56. PubMed ID: 9694076 [Abstract] [Full Text] [Related]
26. Detection of osteoclastic cell-cell fusion through retroviral vector packaging. Kondo T, Ikeda K, Matsuo K. Bone; 2004 Nov; 35(5):1120-6. PubMed ID: 15542037 [Abstract] [Full Text] [Related]
27. [Bio-safety testing for retroviral vector as gene therapy delivery system]. Zhu M, Dai Y. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Mar; 13(1):48-50. PubMed ID: 12759953 [Abstract] [Full Text] [Related]
28. A safe packaging line for gene transfer: separating viral genes on two different plasmids. Markowitz D, Goff S, Bank A. J Virol; 1988 Apr; 62(4):1120-4. PubMed ID: 2831375 [Abstract] [Full Text] [Related]
29. Role of a heterologous retroviral transport element in the development of genetic complementation assay for mouse mammary tumor virus (MMTV) replication. Rizvi TA, Ali J, Phillip PS, Ghazawi A, Jayanth P, Mustafa F. Virology; 2009 Mar 15; 385(2):464-72. PubMed ID: 19157480 [Abstract] [Full Text] [Related]
30. Virofection: a one-step procedure for using replication-defective retrovirus vectors. Flamant F, Samarut J. Virology; 1995 Aug 01; 211(1):234-40. PubMed ID: 7645216 [Abstract] [Full Text] [Related]
31. The expression of full length Gp91-phox protein is associated with reduced amphotropic retroviral production. Bellantuono I, Lashford LS, Rafferty JA, Fairbairn LJ. Haematologica; 2000 May 01; 85(5):451-7. PubMed ID: 10800158 [Abstract] [Full Text] [Related]
32. Construction of new retroviral producer cells from adenoviral and retroviral vectors. Lin X. Gene Ther; 1998 Sep 01; 5(9):1251-8. PubMed ID: 9930327 [Abstract] [Full Text] [Related]
33. A novel human amphotropic packaging cell line: high titer, complement resistance, and improved safety. Rigg RJ, Chen J, Dando JS, Forestell SP, Plavec I, Böhnlein E. Virology; 1996 Apr 01; 218(1):290-5. PubMed ID: 8615038 [Abstract] [Full Text] [Related]
34. Stable expression of the ecotropic retrovirus receptor in amphotropic packaging cells facilitates the transfer of recombinant vectors and enhances the yield of retroviral particles. Gerstmayer B, Groner B, Wels W, Schnierle BS. J Virol Methods; 1999 Aug 01; 81(1-2):71-5. PubMed ID: 10488763 [Abstract] [Full Text] [Related]
35. Retrovirus vectors designed for efficient transduction of cytotoxic or cytostatic genes. Ui M, Takada M, Arai T, Matsumoto K, Yamada K, Nakahata T, Nishiwaki T, Furukawa Y, Tokino T, Nakamura Y, Iba H. Gene Ther; 1999 Oct 01; 6(10):1670-8. PubMed ID: 10516715 [Abstract] [Full Text] [Related]
36. [Retroviral-mediated transfer of beta-globin gene into human hematopoietic cells]. Gao C, Xu Y, Zhang J, Liu D. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Oct 01; 18(5):353-7. PubMed ID: 9388961 [Abstract] [Full Text] [Related]
37. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors. Kikuchi E, Menendez S, Ozu C, Ohori M, Cordon-Cardo C, Logg CR, Kasahara N, Bochner BH. Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4511-8. PubMed ID: 17671137 [Abstract] [Full Text] [Related]
38. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells. Fischer YH, Miletic H, Giroglou T, Litwak S, Stenzel W, Neumann H, von Laer D. J Gene Med; 2007 May 01; 9(5):335-44. PubMed ID: 17474071 [Abstract] [Full Text] [Related]
39. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Danos O, Mulligan RC. Proc Natl Acad Sci U S A; 1988 Sep 01; 85(17):6460-4. PubMed ID: 3413107 [Abstract] [Full Text] [Related]
40. Transduction efficiency of cell lines and hematopoietic stem cells correlates with retrovirus receptor mRNA levels. Orlic D, Girard LJ, Anderson SM, Do BK, Seidel NE, Jordan CT, Bodine DM. Stem Cells; 1997 Sep 01; 15 Suppl 1():23-8; discussion 28-9. PubMed ID: 9368321 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]